Prevail Stent Study for Heart Disease
Part of Heart & circulation clinical trials.
This study tests a new type of stent for people with narrowed heart arteries causing chest pain or a recent mild heart attack. It aims to see if the stent is safe and effective in improving blood flow without serious side effects.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 or older
- You have chest pain (angina) or a positive stress test, or a recent mild heart attack that is stable
- You are expected to live more than 1 year
- You are not allergic to blood thinners or the X-ray dye used in the procedure
- You do not have severe kidney disease or a history of stroke
- You have not had a stent in the target artery in the last 6 months
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial compares two treatments—stents and paclitaxel-coated balloons—for people with narrowed heart arteries that are small, long, or complex. It aims to find which option works better to restore blood flow.
This trial tests a new stent (a small mesh tube) to open narrowed heart arteries and improve blood flow. It may help people with multiple blocked arteries who are having a procedure to widen them.
This study compares two types of devices used to open blocked heart arteries during a heart attack or unstable chest pain: one is a scaffold made of magnesium that dissolves over time, the other is a permanent stent with a coating that releases medicine. The goal is to see which device works better for patients like you.
This study tests a drug-coated balloon (DCB) that releases two medicines (sirolimus and paclitaxel) to open blocked small heart arteries. It may help people with stable chest pain or recent, controlled heart events who have a narrowed small vessel.
This study compares two ways to open blocked heart arteries: one uses a balloon coated with medicine, and the other uses a small mesh tube (stent) that releases medicine. The goal is to see which works better for people with chest pain or a recent heart attack.
This study tests whether taking a single blood-thinning medication (instead of two) after heart stent placement is safe and effective over the long term. If you've recovered well from a stent procedure, this trial may help determine the safest way to prevent future heart problems.
Hear when a new Coronary artery disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.